✦ LIBER ✦

2( S )-((3,5-Bis(trifluoromethyl)benzyl)oxy)-3( S )-phenyl-4-((3-oxo-1,2,4-triazol- 5-yl)methyl)morpholine ( 1 ): A Potent, Orally Active, Morpholine-Based Human Neurokinin-1 Receptor Antagonist

✍ Scribed by Hale, Jeffrey J.; Mills, Sander G.; MacCoss, Malcolm; Shah, Shrenik K.; Qi, Hongbo; Mathre, David J.; Cascieri, Margaret A.; Sadowski, Sharon; Strader, Catherine D.; MacIntyre, D. Euan; Metzger, Joseph M.

Book ID: 120546944
Publisher: American Chemical Society
Year: 1996
Tongue: English
Weight: 140 KB
Volume: 39
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm950654w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: 2(S)-((3,5-Bis(trif

ChemInform Abstract: 2(S)-((3,5-Bis(trifluoromethyl)benzyl)oxy)-3(S)-phenyl-4-((3-oxo-1,2,4- triazol-5-yl)methyl)morpholine: A Potent, Orally Active, Morpholine- Based Human Neurokinin-1 Receptor Antagonist.

✍ J. J. HALE; S. G. MILLS; M. MACCOSS; S. K. SHAH; H. QI; D. J. MATHRE; M. A. CASC 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB

Structural Optimization Affording 2-( R

Structural Optimization Affording 2-( R )-(1-( R )-3,5-Bis(trifluoromethyl)phenylethoxy)-3-( S )-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

✍ Hale, Jeffrey J.; Mills, Sander G.; MacCoss, Malcolm; Finke, Paul E.; Cascieri, 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 189 KB

2-[(3a R ,4 R ,5 S ,7a S )-5-{(1 S )-1-[

2-[(3a R ,4 R ,5 S ,7a S )-5-{(1 S )-1-[3,5-Bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2 H -isoindol-2-yl]-1,3-oxazol-4(5 H )-one: A Potent Human NK 1 Receptor Antagonist with Multiple Clearance Pathways

✍ Kassick, Andrew J.; Jiang, Jinlong; Bunda, Jaime; Wilson, David; Bao, Jianming; 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 949 KB

ChemInform Abstract: N-[(R,R)-(E)-1-(4-C

ChemInform Abstract: N-[(R,R)-(E)-1-(4-Chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl] -N-methyl-3,5-bis-trifluoromethyl-benzamide: An Orally Active Neurokinin NK1/NK2 Antagonist.

✍ Marc Gerspacher; Andreas von Sprecher; Robert Mah; Gary P. Anderson; Claude Bert 📂 Article 📅 2000 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

Stereoselective Preparation of N -[( R,R

Stereoselective Preparation of N -[( R,R )-( E )-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl- N -methyl-3,5-bis(trifluoromethyl)benzamide, a Potent and Orally Active Dual Neurokinin NK 1 /NK 2 Receptor Antagonist

✍ Gerspacher, Marc; Lewis, Christine; Ball, Howard A.; Howes, Colin; Subramanian, 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 99 KB

(+)-(2R,5S)-4-[4-Cyano-3-(trifluoromethy

(+)-(2R,5S)-4-[4-Cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an Orally Potent and Peripherally Selective Nonsteroidal Androgen Receptor Antagonist1

✍ Kinoyama, Isao; Taniguchi, Nobuaki; Toyoshima, Akira; Nozawa, Eisuke; Kamikubo, 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 300 KB